X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (261) 261
positron emission tomography (217) 217
pet (188) 188
clinical neurology (150) 150
neurosciences (150) 150
positron-emission-tomography (149) 149
male (146) 146
radiology, nuclear medicine & medical imaging (134) 134
female (130) 130
parkinson's disease (121) 121
index medicus (115) 115
tomography, emission-computed (112) 112
middle aged (111) 111
parkinson disease - diagnostic imaging (101) 101
dihydroxyphenylalanine - analogs & derivatives (97) 97
parkinsons-disease (87) 87
aged (86) 86
animals (86) 86
brain (72) 72
multiple system atrophy (68) 68
adult (64) 64
positron-emission tomography (64) 64
dopamine (63) 63
brain - diagnostic imaging (60) 60
fluorine radioisotopes (60) 60
progressive supranuclear palsy (59) 59
dopamine - metabolism (58) 58
parkinson disease - metabolism (53) 53
metabolism (52) 52
f-18 dopa pet (51) 51
radiopharmaceuticals (49) 49
f-18 dopa-pet (48) 48
in-vivo (46) 46
brain - metabolism (45) 45
corpus striatum - metabolism (43) 43
positron-emission tomography - methods (43) 43
pet imaging (42) 42
substantia-nigra (41) 41
basal ganglia (40) 40
diagnosis (40) 40
medicine & public health (40) 40
parkinson disease - physiopathology (40) 40
dihydroxyphenylalanine - pharmacokinetics (39) 39
f-18 dopa uptake (39) 39
kinetics (38) 38
corpus striatum - diagnostic imaging (36) 36
f-18 (36) 36
f-18 dopa (36) 36
magnetic resonance imaging (36) 36
tomography (36) 36
imaging / radiology (34) 34
neuroimaging (34) 34
parkinson disease - diagnosis (33) 33
rats (33) 33
6-fluoro-l-dopa (32) 32
fluorodeoxyglucose f18 (32) 32
tomography, emission-computed - methods (32) 32
disease (31) 31
f-18 fluorodeoxyglucose (31) 31
progression (31) 31
spect (31) 31
oncology (30) 30
parkinson disease - pathology (29) 29
striatonigral degeneration (29) 29
endocrinology & metabolism (28) 28
radiopharmaceuticals - pharmacokinetics (28) 28
diagnosis, differential (27) 27
nuclear medicine (27) 27
time uptake data (27) 27
tomography, emission-computed, single-photon (27) 27
tumors (27) 27
chemistry, inorganic & nuclear (25) 25
dementia (25) 25
parkinson disease - drug therapy (25) 25
parkinsons disease (25) 25
putamen - diagnostic imaging (25) 25
dopa (24) 24
graphical evaluation (24) 24
disease progression (23) 23
pharmacology & pharmacy (23) 23
6-[f-18]fluoro-l-dopa (22) 22
sensitivity and specificity (22) 22
brain transfer constants (21) 21
c-11 raclopride (21) 21
cancer (21) 21
fluorodopa (21) 21
neuroendocrine tumors (21) 21
striatum (21) 21
differential-diagnosis (20) 20
dihydroxyphenylalanine - metabolism (20) 20
mri (20) 20
orthopedics (20) 20
alzheimers-disease (19) 19
brain mapping (19) 19
chemistry, organic (19) 19
neurons (19) 19
reference values (19) 19
substantia nigra - pathology (19) 19
tissue distribution (19) 19
cardiology (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2018, Volume 45, Issue 12, pp. 2159 - 2169
Journal Article
Human Brain Mapping, ISSN 1065-9471, 10/2007, Volume 28, Issue 10, pp. 931 - 939
Dopamine neurotransmission influences those cognitive processes, which are generally regarded as prefrontal cortical functions. In previous... 
attention | set shifting | [18F]‐fluoro‐l‐DOPA | interference | striatum | dopamine | F]-fluoro-L-DOPA | Striatum | Dopamine | Set shifting | Attention | Interference | LIVING BRAIN | SCHIZOPHRENIC-PATIENTS | HUMANS | NEUROSCIENCES | NEUROIMAGING | POSITRON-EMISSION-TOMOGRAPHY | CORTEX | [F-18]-fluoro-L-DOPA | DOPAMINE SYNTHESIS CAPACITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | WORKING-MEMORY | PARKINSONS-DISEASE | AGE | Basal Ganglia - diagnostic imaging | Synaptic Transmission - physiology | Mesencephalon - metabolism | Humans | Middle Aged | Basal Ganglia - metabolism | Dihydroxyphenylalanine - analogs & derivatives | Male | Reference Values | Positron-Emission Tomography | Dihydroxyphenylalanine - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Cognition - physiology | Adult | Functional Laterality - physiology | Dopamine - metabolism | Putamen - diagnostic imaging | Reaction Time - physiology | Blood-Brain Barrier - drug effects | Metabolic Clearance Rate - physiology | Blood-Brain Barrier - metabolism | Caudate Nucleus - metabolism | Neuropsychological Tests | Mesencephalon - diagnostic imaging | Caudate Nucleus - diagnostic imaging | Dihydroxyphenylalanine - metabolism | Neural Pathways - diagnostic imaging | Prefrontal Cortex - metabolism | Brain Mapping | Neural Pathways - metabolism | Prefrontal Cortex - diagnostic imaging | Putamen - metabolism
Journal Article
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, ISSN 0021-972X, 12/2009, Volume 94, Issue 12, pp. 4757 - 4767
Context: Besides I-123-metaiodobenzylguanidine (MIBG), positron emission tomography (PET) agents are available for the localization of paraganglioma (PGL),... 
METASTATIC PHEOCHROMOCYTOMA | POSITRON-EMISSION-TOMOGRAPHY | NEUROENDOCRINE TUMORS | MIBG SCINTIGRAPHY | METAIODOBENZYLGUANIDINE | TRANSPORTERS | HIPPEL-LINDAU-SYNDROME | ENDOCRINOLOGY & METABOLISM | ENDOCRINE NEOPLASIA TYPE-2 | F-18 DOPA PET | I-123-METAIODOBENZYLGUANIDINE
Journal Article
Journal Article
Brain : a journal of neurology, ISSN 0006-8950, 04/1996, Volume 119, Issue 2, pp. 585 - 591
Journal Article
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 12/1995, Volume 59, Issue 6, pp. 597 - 600
Twenty seven patients with recent onset (mean symptom duration 22 (SD 14) months, Hoehn and Yahr score 1.8 (SD 0.7)) Parkinson's disease were studied with... 
Tomography | Parkinson's disease | Preclinical disease | Positron emission tomography | F-18 DOPA | PRECLINICAL DISEASE | FLUORODOPA | PSYCHIATRY | POSITRON EMISSION TOMOGRAPHY | PARKINSONS DISEASE | CLINICAL NEUROLOGY
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 10/2007, Volume 48, Issue 10, pp. 1599 - 1606
Journal Article
ANNALS OF NEUROLOGY, ISSN 0364-5134, 12/2002, Volume 52, Issue 6, pp. 849 - 853
PARK6, a locus for early-onset recessive parkinsonism, has been causally implicated in nine unrelated families from four different countries. The gene is still... 
SYSTEM | DISEASE | F-18 DOPA-PET | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
CLINICAL ENDOCRINOLOGY, ISSN 0300-0664, 12/2014, Volume 81, Issue 6, pp. 789 - 798
F-18-FDOPA (6-[18F]-L-fluoro-L-3, 4-dihydroxyphenylalanine)-based PET/CT imaging can be a useful tool for the detection of different neuroendocrine tumours... 
UNKNOWN ORIGIN | ADULT PATIENTS | POSITRON-EMISSION-TOMOGRAPHY | F-18-DOPA PET | GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS | LIMITED VALUE | ENDOCRINOLOGY & METABOLISM | MEDULLARY-THYROID CARCINOMA | SOMATOSTATIN RECEPTOR SCINTIGRAPHY | F-18 DOPA PET | FOCAL CONGENITAL HYPERINSULINISM
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 04/2008, Volume 49, Issue 4, pp. 573 - 586
In recent years, 6-L-F-18-fluorodihydroxyphenylalanine (F-18-DOPA) PET has emerged as a new diagnostic tool for the imaging of neuroendocrine tumors. This... 
AMINO-ACID DECARBOXYLASE | CONGENITAL HYPERINSULINISM | CARBIDOPA PRETREATMENT | FOCAL HYPERINSULINISM | MEDULLARY-THYROID CARCINOMA | carcinoid | POSITRON-EMISSION-TOMOGRAPHY | F-18-FDOPA PET | IN-VIVO | ENDOSCOPIC ULTRASONOGRAPHY | F-18 DOPA PET | F-18-DOPA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | neuroendocrine tumors
Journal Article
CLINICAL ENDOCRINOLOGY, ISSN 0300-0664, 10/2008, Volume 69, Issue 4, pp. 580 - 586
Background F-18-DOPA has emerged as a promising tool in the localization of chromaffin-tissue-derived tumours. Interestingly, phaeochromocytomas (PHEO) are... 
LOCALIZATION | DIAGNOSIS | POSITRON-EMISSION-TOMOGRAPHY | METAIODOBENZYLGUANIDINE | ENDOCRINOLOGY & METABOLISM | FDG | ADRENOCORTICAL CARCINOMA | PARAGANGLIOMA | F-18 DOPA PET | MUTATIONS | TUMORS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.